Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-23T21:34:06.779Z Has data issue: false hasContentIssue false
  • English
  • Français

Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes

Published online by Cambridge University Press:  07 November 2014

Jeffrey L. Jackson ,
Patrick G. O'Malley  and
Kurt Kroenke
Get access Rights & Permissions [Opens in a new window]

Abstract

Somatic symptoms are common in primary care and clinicians often prescribe antidepressants as adjunctive therapy. There are many possible reasons why this may work, including treating comorbid depression or anxiety, inhibition of ascending pain pathways, inhibition of prefrontal cortical areas that are responsible for “attention” to noxious stimuli, and the direct effects of the medications on the syndrome.There are good theoretical reasons why antidepressants with balanced norepinephrine and serotonin effects may be more effective than those that act predominantly on one pathway, though head-to-head comparisons are lacking. For the 11 painful syndromes review in this article, cognitive-behavioral therapy is most consistently demonstrated to be effective, with various antidepressants having more or less randomized controlled data supporting or refuting effectiveness.This article reviews the randomized controlled trial data for the use of antidepressant and cognitive-behavior therapy for 11 somatic syndromes: irritable bowel syndrome, chronic back pain, headache, fibromyalgia, chronic fatigue syndrome, tinnitus, menopausal symptoms, chronic facial pain, noncardiac chest pain, interstitial cystitis, and chronic pelvic pain. For some syndromes, the data for or against treatment effectiveness is relatively robust, for many, however, the data, one way or the other is scanty.

Type
Review Articles
Information
CNS Spectrums , Volume 11 , Issue 3 , March 2006 , pp. 212 - 222
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Whitehead, WE, Palsson, O, Jones, KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–1156Google Scholar
2.Lake, AE 3rd, Rains, JC, Penzien, DB, Lipchik, GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45:493–506.Google Scholar
3.Patten, SB, Beck, CA, Kassam, A, Williams, JV, Barbui, C, Metz, LM. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry. 2005;50:195–202.Google Scholar
4.Bonaz, B, Baciu, M, Papillon, E, et al.Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654–656.Google Scholar
5.Drossman, DA, Toner, BB, Whitehead, WE, et al.Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31.CrossRefGoogle ScholarPubMed
6.Jackson, JL. Somatic and vegetative symptoms in depression. Depression, Mind and Body. 2004;1:42–49.Google Scholar
7.Damatarca, C. Pain and depression: bridging the body and mind. Depression, Mind and Body. 2003;1:7–13.Google Scholar
8.Jones, SL. Descending noradrenergic influences on pain. Prog Brain Res. 1991;88:391–394.Google Scholar
9.Richardson, BP. Serotonin and nocioception. Ann N Y Acad Sci. 1990;600:511–519.Google Scholar
10.Stahl, SM. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry. 2002;63:382–383.Google Scholar
11.Willis, WD, Westlund, KN. Neuroanatomy of the pain system and the pathways that modulate pain. J Clin Neurophysiol. 1997;14:2–31.Google Scholar
12.Naliboff, BD, Munakata, J, Fullerton, S, et al.Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41:505–512.Google Scholar
13.Petzke, F, Harris, RE, Williams, DA, Clauw, DJ, Gracely, RH. Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls. Eur J Pain. 2005;9:325–335.Google Scholar
14.Montoya, P, Pauli, P, Batra, A, Wiedemann, G. Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain. 2005;9:293–303.Google Scholar
15.Gorard, DA, Libby, GW, Farthing, MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:159–166.CrossRefGoogle ScholarPubMed
16.Kroenke, K, Swindle, R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–215.CrossRefGoogle ScholarPubMed
17.Allen, LA, Escobar, JL, Lehrer, PM, Gara, MA, Woolfolk, RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med. 2002;64:939–950.Google Scholar
18.Lackner, JM, Lou Coad, M, Mertz, HR, et al.Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, Gl symptoms, and anxiety. Behav Res Ther. 2005 Jul 20; [Epub ahead of print].Google Scholar
19.Brandt, LJ, Bjorkman, D, Fennerty, MB, Locke, GR, Olden, K, Peterson, Wet al.Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 suppl):S7–S26.Google ScholarPubMed
20.Thompson, WG, Heaton, KW, Smyth, GT, Smyth, C. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol. 1997;9:689–692.Google Scholar
21.Gladman, LM, Gorard, DA. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders. Aliment Pharmacol Ther. 2003;17:651–654.Google Scholar
22.American College of Gastroenterology Functional Gastrointestinal Disorders Task Froce. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 Suppl):S1–S5.Google Scholar
23.Guilera, M, Balboa, A, Mearin, F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol. 2005;100:1174–1184.Google Scholar
24.Koloski, NA, Talley, NJ, Boyce, PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001;96:1340–1349.Google Scholar
25.Clouse, RE. Antidepressants for irritable bowel syndrome. Gut. 2003;52:598–599.Google Scholar
26.Lesbros-Pantoflickova, D, Michetti, PFried, M, Beglinger, C, Blum, AL. Meta-analysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20:1253–69.Google Scholar
27.Jailwala, J, Imperiale, TF, Kroenke, K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000;133:136–147.Google Scholar
28.Jackson, JL, O'Malley, PG, Tomkins, G, Balden, E, Santoro, J, Kroenke, K. Treatment of functional gastrointestinal disorders with antidepressant medications: a metaanalysis. Am J Med. 2000;108:65–72.Google Scholar
29.Kazis, LE, Anderson, JJ, Meenan, RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(3 suppl):S178–S189.Google Scholar
30.Tabas, G, Beaves, M, Wang, J, Friday, P, Mardini, H, Arnold, G. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterol. 2004;99:914–920.Google Scholar
31.Kuiken, SD, Tytgat, GN, Boeckxstaens, GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol. 2003;1:219–228Google Scholar
32.Toner, BB, Segal, ZV, Emmot, S, et al.Cognitive-behavioral group therapy for patients with irritable bowel syndrom. Int J Group Psychother. 1998;48:215–243.Google Scholar
33.Hutton, J. Cognitive behaviour therapy for irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17:11–14Google Scholar
34.Kennedy, T, Jones, R, Darnley, S, Seed, RWessely, S, Chalder, T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ. 2005;331:435.Google Scholar
35.Shaw, G, Srivastava, ED, Sadlier, M, Swann, P, James, JY, Rhodes, J. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:36–42.Google Scholar
36.Bennett, P, Wilkinson, S. A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psychol. 1985;24(pt3):215–216.Google Scholar
37.Heymann-Monnikes, I, Arnold, R, Florin, I, Herda, C, Melfsen, S, Monnikes, H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981–994.Google Scholar
38.Boyce, PM, Talley, NJ, Balaam, B, Koloski, NA, Truman, G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003;98:2209–2218.Google Scholar
39.Hart, LG, Deyo, RA, Cherkin, DC. Hart, LG, Deyo, RA, Cherkin, DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine. 1995;20:11–19.Google Scholar
40.Maniadakis, N, Gray, A. The economic burden of back pain in the UK. Pain. 2000;84:95–103.Google Scholar
41.Von Korff, M, Saunders, K. The course of back pain in primary care. Spine. 1996;21:2833–2837.Google Scholar
42.Salerno, SM, Browning, R, Jackson, JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med. 2002;162:19–24.Google Scholar
43.Staiger, TO, Gaster, B, Sullivan, MD, Deyo, RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003;28:2540–2545.CrossRefGoogle ScholarPubMed
44.Schnitzer, TJ, Ferraro, A, Hunsche, E, Kong, SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. J Pain Symptom Manage. 2004;28:72–95.CrossRefGoogle ScholarPubMed
45.Jenkins, DG, Ebbutt, AF, Evans, CD. Tofranil in the treatment of low back pain. J Int Med Res. 1976;4(2 Suppl):28–40.Google Scholar
46.Alcoff, J, Jones, E, Rust, Ret al.Controlled trial of imipramine for chronic low back pain. J Fam Pract. 1982;14:841–846.Google Scholar
47.Pheasant, H, Bursk, A, Goldfarb, J, et al.Amitriptyline and chronic low-back pain. A randomized doubleblind crossover study. Spine. 1983;8:552–557.Google Scholar
48.Goodkin, K, Gullion, CM, Agras, WS. A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol. 1990;10:269–278.Google Scholar
49.Atkinson, JH, Slater, MA, Williams, RA, et al.A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76:287–296.Google Scholar
50.Atkinson, JH, Slater, MA, Wahlgren, DR, et al.Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain. 1999;83:137–145.Google Scholar
51.Dickens, C, Jayson, M, Sutton, C, Creed, F. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics. 2000;41:490–499.Google Scholar
52.Ward, N, Bokan, JA, Phillips, M, Benedetti, C, Butler, S, Spengler, D. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry. 1984;45(3 pt 2):54–59.Google Scholar
53.Schreiber, S, Vinokur, S, Shavelzon, V, Pick, CG, Zahavi, E, Shir, Y. A randomized trial of fluoxetine versus amitriptyline in musculoskeletal pain. Isr J Psychiatry Relat Sci. 2001;38:88–94.Google Scholar
54.Hameroff, SR, Weiss, J, Lerman, JC. et al.Doxepin's effects on chronic pain and depression. J Clin Psychiatry. 1984;45(3 pt 2):47–52.Google Scholar
55.O'Malley, PG, Jackson, JL, Tomkins, G, Santoro, J, Balden, E, Kroenke, K. Antidepressant therapy for unexplained symptoms and symptom syndromes: a critical review. J fam Pract. 1999;48:980–993.Google Scholar
56.Jung, AC, Staiger, T, Sullivan, M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997;12:384–389.Google Scholar
57.Onghena, RVan Houdenhove, B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992;49:205–219.Google Scholar
58.Grothe, DR. Scheckner, B, Albano, D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy. 2004;24:621–629.Google Scholar
59.Raine, R, Haines, A, Sensky, T, Hutchings, A, Larkin, K, Black, N. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? BMJ. 2002;325:1082.Google Scholar
60.van Tulder, MW, Koes, BW, Bouter, LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine. 1997;22:2128–2156.Google Scholar
61.Lorig, KR, Holman, H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.Google Scholar
62.Rasmussen, BK, Olesen, J. Epidemiology of headache in a general population: a prevalence study. Curr Opin Neurol. 1994;7:264–227.Google Scholar
63.Hu, XH, Markson, LE, Lipton, RB, Stewart, WF, Berger, ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813–818.Google Scholar
64.Taylor, FR. Diagnosis and classification of headache. Prim Care. 2004;31:243–259.Google Scholar
65.Lake, AE 3rd, Rains, JC, Penzien, DB, Lipchik, GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45:493–506.CrossRefGoogle ScholarPubMed
66.Gesztelyi, G, Bereczki, D. Disability is the major determinant of the severity of depressive symptoms in primary headaches but not in low back pain. Cephalalgia. 2005;25:598–604.Google Scholar
67.Torelli, P, D'Amico, D. An updated review of migraine and co-morbid psychiatric disorders. Neurol Sci. 2004;25(suppl 3):S234–S235.Google Scholar
68.Tomkins, GE, Jackson, JL, O'Malley, PG, Balden, E, Santoro, JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med. 2001;111:54–63.Google Scholar
69.Lance, JW, Curran, DA. Treatment of chronic tension headache. Lancet. 1964;1:1236–1239.Google Scholar
70.Moja, PL, Cusi, C, Sterzi, RR, Canepari, C. Selective Serotonin Re-uptake Inhibitors for Preventing Migraine and Tension-Type Heaches. Cochrane Database Syst Rev. 2005:CD002919.Google Scholar
71.Rains, JC, Penzien, DB, McCrory, DC, Gray, RN. Behavioral Headache Treatment: History, Review of the Empirical Literature, and Methodological Critique. Headache. 2005;45(suppl 2):S92–S109.Google Scholar
72.Linde, K, Rossnagel, K. Propranolol for migraine prophylaxis. Cochrane Database Syst flev. 2004;(4):CD003225.Google Scholar
73.Melchart, D, Streng, A, Hoppe, A, et al.Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ. 2005;331:376–382.Google Scholar
74.Silberstein, SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–762.Google Scholar
75.Schrader, H, Stovner, LJ, Helde, G, Sand, T, Bovim, G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001;322:19–22.Google Scholar
76.Tronvik, E, Stovner, LJ, Helde, G, Sand, T, Bovim, G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289:65–69.Google Scholar
77.Ernst, E. Manual therapies for pain control: chiropractic and massage. Clin J Pain. 2004;20:8–12.Google Scholar
78.Yunus, MD, Kalayan-Raman, UP, Masi, AT, Aldag, AT. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol. 1989;16:97–10Google Scholar
79.Simms, RW, Roy, SH, Hrovat, M, et al.Lack of association between fibromyalgia syndrome and abnormalities and muscle energy metabolism. Arthritis Rheum. 1994;37:794–800.Google Scholar
80.Pillemer, SR, Bradley, LA, Crofford, LJ, Moldofsky, H, Chrousos, GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum. 1997;40:1928–1939Google Scholar
81.Wolfe, F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:1–17Google Scholar
82.Goldenberg, DL, Burckhardt, C, Crofford, L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–2395.Google Scholar
83.Arroyo, JF, Cohen, ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 1993;20:1925–1931.Google Scholar
84.Kosek, E, Ekholm, J, Hansson, PModulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain. 1996;64:415–423.Google Scholar
85.Kosek, E, Ekholm, J, Hansson, P. Increased pressure pain sensibility in fibromyalgia patients is located deep in the skin but not restricted to muscle tissue. Pain. 1995;63:335–339.Google Scholar
86.Drewes, AM, Gade, K, Nielsen, KD, Bjerregard, K, Taagholt, SJ, Svendsen, L. Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol. 1995;34:1151–1156.Google Scholar
87.May, KRWest, SG, Baker, MR, Everett, DW. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med. 1993;94:505–508.Google Scholar
88.Yunus, MB, Aldag, JC. Restless leg syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.Google Scholar
89.MacFarlane, JG, Shahal, B, Mously, C, Moldofsky, H. Periodic K-alpha sleep EEG activity and periodic limb movements during sleep: comparisons of clinical features and sleep parameters. Sleep. 1996;19:200–204.Google Scholar
90.Hudson, JL, Goldenberg, DL, Pope, HG Jr, Keck, PE Jr, Schlesinger, L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363–367.Google Scholar
91.Triadafilopoulos, G, Simms, RW, Goldenberg, DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci. 1991;36:59–64.Google Scholar
92.Ahles, TA, Khan, SA, Yunus, MB, Spiegell, DA, Masi, AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry. 1991;148:1721–1726.Google Scholar
93.O'Malley, PG, Balden, E, Tomkins, G, Santoro, J, Kroenke, K, Jackson, JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med. 2000;15:659–666.Google Scholar
94.Goldenberg, D, Mayskiy, M, Mossey, C, Ruthazer, R, Schmid, C. A randomized, double-blind, crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:1852–1859.Google Scholar
95.Carette, S, McCain, GA, Bell, DA, Fam, AG. Evaluation of amitriptyline in primary fibro-sitis. A double-blind placebo-controlled study. Arthritis Rheum. 1986;29:655–659.Google Scholar
96.Hannonen, P, Malminiemi, K, Yli-Kerttula, U, Isomeri, R, Roponen, P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol. 1998;37:1279–1286.Google Scholar
97.Wolfe, F, Cathey, MA, Hawley, DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255–259.Google Scholar
98.Norregaard, J, Volkmann, H, Danneskiold-Samsoe, B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445–449.Google Scholar
99.Arnold, LM, Hess, EV, Hudson, JL, Welge, JA, Berno, SE, Keck, PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191–197.Google Scholar
100.Arnold, LM, Lu, Y, Crofford, LJ, et al.A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974–2984.Google Scholar
101.Williams, DA. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003;17:649–665.Google Scholar
102.Hadhazy, VA, Ezzo, J, Creamer, P, Berman, BM. Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol. 2000;27:2911–2918.Google Scholar
103.Tofferi, JK, O'Malley, PG, Jackson, JL. Treatment of fibromyalgia with cyclobenzap-rine: A meta-analysis. Arthritis Rheum. 2004;51:9–13.Google Scholar
104.Sharpe, M, O'Malley, PG. Chronic fatigue and fibromyalgia syndromes. In: Levinson, J, ed. Textbook of Consultation-Liaison Psychiatry, 1st ed. Washington, DC: American Psychiatric Press; 2004;108–134Google Scholar
105.Fukuda, K, Straus, SE, Hickie, IB, Sharpe, M, Dobbins, JG, Komaroff, AL. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–959.Google Scholar
106.Sullivan, PF, Pedersen, NL, Jacks, A, Evengard, B. Chronic fatigue in a population sample: definitions and heterogeneity. Psychol Med. 2005;35:1337–1348.Google Scholar
107.Darbishire, L, Ridsdale, L, Seed, PT. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. Br J Gen Pract. 2003;53:441–445.Google Scholar
108.Whiting, P, Bagnall, AM, Sowden, AJ, Cornell, JE, Mulrow, CD, Ramirez, G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA. 2001;286:1360–1368.Google Scholar
109.Natelson, BH, Cheu, J, Pareja, J, Ellis, SRPolicastro, T, Findley, TW. Randomized, bouble blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology. 1996;124:226–230.Google Scholar
110.Vercoulen, JH, Swanink, CM, Zitman, FG, et al.Randomized double-blind placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet. 1996;347:858–861.Google Scholar
111.Hickie, IB, Wilson, AJ, Wright, JM, Bennet, BK, Wakefield, D, Lloyd, AR. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry. 2000;61:643–648.Google Scholar
112.Wearden, AJ, Morriss, RK, Mullis, R, et al.Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry. 1998;172:485–490.Google Scholar
113.Sharpe, M, Hawton, K, Simkin, S, et al.Cognitive behavior therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ. 1996; 12:22–26.Google Scholar
114.Deale, AChalder, XMarks, I, Wessely, S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry. 1997;154:408–414.Google ScholarPubMed
115.Lloyd, AR, Hickie, I, Brockman, A, et al.Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med. 1993;94:197–203.Google Scholar
116.Friedberg, F, Krupp, LB. A comparison of cognitive behavior treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis. 1994;18(suppl 1):S105–S110.Google Scholar
117.Stulemeijer, M, de Jong, LW, Fiselier, TJ, Hoogveld, SW, Bleijenberg, G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ. 2005;330:14.Google Scholar
118.Huibers, MJ, Beurskens, AJ, Van Schayck, CP, et al.Efficacy of cognitive-behavioural therapy by general practitioners for unexplained fatigue among employees: randomised controlled trial. Br J Psychiatry. 2004;184:240–246.Google Scholar
119.Ridsdale, L, Darbishire, L, Seed, PT. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care. Psychol Med. 2004;34:37–49.Google Scholar
120.Deale, A, Husain, K, Chalder, T, Wessely, S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry. 2001;158:2038–2042.Google Scholar
121.Sullivan, M, Katon, W, Russo, J, Dobie, R, Sakai, C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med. 1993;153:2251–2259.Google Scholar
122.Mihail, RC, Crowley, JM, Walden, BE, Fishburne, J, Reinwall, JE, Zajtchuk, JT. The tricyclic trimipramine in the treatment of subjective tinnitus. Ann Otol Rhinol Laryngol. 1988;97:120–123.Google Scholar
123.Kroner-Herwig, B, Frenzel, A, Fritsche, G, Schilkowsky, G, Esser, G. The management of chronic tinnitus: comparison of an outpatient cognitive-behavioral group training to minimal-contact interventions. J Psychosom Res. 2003;54:381–389.Google Scholar
124.Zachriat, C, Kroner-Herwig, B. Treating chronic tinnitus: comparison of cognitive-behavioural and habituation-based treatments. Cogn Behav Ther. 2004;33:187–198.Google Scholar
125.Andersson, G, Lyttkens, L. A meta-analytic review of psychological treatments for tinnitus. Br J Audiol. 1999;33:201–210.Google Scholar
126.Stearns, V, Beebe, KL, Iyengar, M, Dube, E. Paroxetine controlled release in the treatment of menopausal hot flashers: a randomized controlled trial. JAMA. 2003;289:2827–2834.Google Scholar
127.Evans, ML, Pritts, E, Vittinghoff, E, McClish, K, Morgan, KS, Jaffe, RB. Management of postmenopausal hot flashes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol. 2005;105:161–166.Google Scholar
128.Loprinzi, CL, Kugler, JW, Sloan, JA, et al.Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356:2059–2063.Google Scholar
129.Feinmann, C, Harris, M, Cawley, R. Psychogenic facial pain: presentation and treatment. Br Med J (Clin Res Ed). 1984;288:436–438.CrossRefGoogle ScholarPubMed
130.Cannon, RO, Quyyumi, AA, Mincemoyer, R, et al.Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;30:1411–1417.Google Scholar
131.Kisely, S, Campbell, LA, Skerritt, P. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2005:CD004101.Google Scholar
132.van Ophoven, A, Pokupic, S, Heinecke, A, Hertle, L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533–536.Google Scholar
133.Engel, CC Jr, Walker, EA, Engel, AL, Bullis, J, Armstrong, A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res. 1998;44:203–207.Google Scholar
134.Henningsen, RZimmermann, T, Sattel, H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–533.Google Scholar